We have used our dCELL® process to decellularise dermis skin patches from donors and these patches - known as DermaPure™ –can then be used to cover chronic wounds. Application is rapid and easy to use with no rehydration required.
For more information on DermaPure™, click here
Our dCELL® technology is being used to develop new regenerative approaches to repairing damaged knees, to potentially avoid synthetic knee replacements. Meniscus injuries are increasingly common, with rising levels of obesity and an increasing number of sports related injuries leading to damaged knee tissue. The meniscus acts like a shock absorber in the knee and more than 850,000 repairs are currently performed each year. dCELL® decellularises porcine meniscus for implanting into the patient’s knee, acting as a matrix which could attract stem-cells and allow natural healing of damaged joints.
Our dCELL® technology enables us to take heart valves from pigs and decellularise the tissue, removing all trace of the porcine DNA and cells, and producing an inert heart valve. The dCELL® process works because it preserves the biomechanical properties of the heart valve and reduces the risk of rejection and infection. Our dCELL® heart valves have ten years of clinical data, showing positive results in more than 1500 patients.
Our dCELL® process takes animal and human tissue and removes the cells, providing a matrix that can be implanted into the body. dCELL® provides a highly biocompatible vascular patch for peripheral vascular reconstruction that evidence suggests gives a framework for population by the patient’s own cells, allowing host tissue regeneration.
dCELL® human dermis patches may allow a better chance of healing for chronic wounds (including ulcers and burns) and potentially faster healing for acute wounds (including surgical incisions and traumatic injuries).
dCELL® heart valves replace the patient’s own damaged valves, and may provide a biological scaffold for population by patient's own cells.
dCELL® decellularises porcine meniscus for implanting into the patient’s knees as a matrix to attract stem-cells and allow natural healing of damaged joints.
dCELL® vascular patches can be used in vascular surgery to provide effective closure with evidence of integration with patient’s own vessel.
Sign up to our mailing list to keep up with the latest news and developments from Tissue Regenix.
View alerts sign-up page
© Tissue Regenix Group plc 2017
Most computers will open PDF documents automatically, but you may need to download Adobe Reader.